Discovery of lung cancer mutations responsive to targeted therapies, immunotherapies
A number of new driver mutations in lung cancer cells has been discovered that may be responsive to genomically targeted therapies and to immunotherapy.
Today's Tech News and Opinion
Leave a Reply